STRUCTURE-ACTIVITY STUDY OF 5-SUBSTITUTED 1-CARBOBENZOXY-2-IMINOHYDANTOINS AS POTENTIAL ANTICONVULSANT AGENTS

被引:21
作者
SUN, ZY [1 ]
KWON, CH [1 ]
WURPEL, JND [1 ]
机构
[1] ST JOHNS UNIV,COLL PHARM & ALLIED HLTH PROFESS,DEPT PHARMACEUT SCI,JAMAICA,NY 11439
关键词
D O I
10.1021/jm00044a003
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
On the basis of our previous findings, a series of 5-substituted 2-iminohydantoins has been synthesized and tested for anticonvulsant activity to better understand the SAR of 2-iminohydantoins. Among the compounds tested, (S)-(+)-1-carbobenzoxy-2-iminohydantoin analogs with ethyl (6)-, n-propyl (7a)-, isopropyl (8)-, allyl (9)-, and sec-butyl (11)-substituted groups at the C5 of the iminohydantoin ring provided the best activities against the MES test with ED(50) values in the range of 52-74 mg/kg. All of the above compounds except 8 also showed activity against the scMET test with ED(50) values in the range of 141-223 mg/kg. All significantly active compounds (1, 6, 7a, 8, 9, and 11) possessed aliphatic hydrocarbon side chains of two- to three-carbon lengths at the C5 position. All of the compounds with no or minimal activity had either shorter or longer side chains. The compounds substituted at the C5 position by aryl groups, arylalkyl groups, or alkyl and arylalkyl groups containing heteroatoms also showed no activity against the MES and scMET tests. The results suggested that the C5 side chain with the correct stereochemistry in 2-iminohydantoins provides optimal anticonvulsant activity when the side chains are aliphatic hydrocarbons with a length, ignoring branching, of two to three carbons.
引用
收藏
页码:2841 / 2845
页数:5
相关论文
共 10 条
[1]   EFFECT OF STRUCTURAL MODIFICATION OF THE HYDANTOIN RING ON ANTICONVULSANT ACTIVITY [J].
CORTES, S ;
LIAO, ZK ;
WATSON, D ;
KOHN, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (05) :601-606
[2]  
KUPFERBERG HJ, 1989, ANTIEPILEPTIC DRUGS, P257
[3]   SYNTHESIS AND ANTICONVULSANT ACTIVITY OF 2-IMINOHYDANTOINS [J].
KWON, CH ;
IQBAL, MT ;
WURPEL, JND .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (06) :1845-1849
[4]   STRUCTURAL REQUIREMENTS FOR CENTRALLY ACTING DRUGS I [J].
LIEN, EJ ;
TONG, GL ;
CHOU, JT ;
LIEN, LL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (02) :246-250
[5]   A new series of anticonvulsant drugs tested by experiments on animals [J].
Merritt, HH ;
Putnam, TJ .
ARCHIVES OF NEUROLOGY AND PSYCHIATRY, 1938, 39 (05) :1003-1015
[6]  
NAKAMURA K, 1965, ARCH INT PHARMACOD T, V156, P261
[7]  
POP E, 1989, EPILEPSY RES, V78, P1787
[8]   ANTIEPILEPTIC DRUG DEVELOPMENT PROGRAM [J].
PORTER, RJ ;
CEREGHINO, JJ ;
GLADDING, GD ;
HESSIE, BJ ;
KUPFERBERG, HJ ;
SCOVILLE, B ;
WHITE, BG .
CLEVELAND CLINIC QUARTERLY, 1984, 51 (02) :293-305
[9]  
ROGAWSKI MA, 1990, PHARMACOL REV, V42, P223
[10]   RAPID CHROMATOGRAPHIC TECHNIQUE FOR PREPARATIVE SEPARATIONS WITH MODERATE RESOLUTION [J].
STILL, WC ;
KAHN, M ;
MITRA, A .
JOURNAL OF ORGANIC CHEMISTRY, 1978, 43 (14) :2923-2925